Healthstream (HSTM) Current Deferred Revenue (2010 - 2026)

Healthstream (HSTM) has reported Current Deferred Revenue for 17 consecutive years, with $93.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Current Deferred Revenue rose 5.21% year-over-year to $93.0 million in Q2 2026; TTM through Jun 2026 was $93.0 million, a 5.21% increase from a year earlier, with the FY2025 full-year figure at $88.4 million, up 4.97% from the prior year.
• Current Deferred Revenue was $93.0 million for Q2 2026 at Healthstream, down from $106.4 million in the prior quarter.
• Over five years, Current Deferred Revenue peaked at $106.4 million in Q1 2026 and troughed at $77.6 million in Q3 2022.
• A 5-year average of $88.2 million and a median of $86.3 million in 2024 frame the typical range for Current Deferred Revenue.
• Across the five-year window, Current Deferred Revenue advanced 7.66% in 2022 and declined 0.34% in 2024, its largest moves.
• Over 5 years, Current Deferred Revenue stood at $79.5 million in 2022, then climbed by 5.23% to $83.6 million in 2023, then grew by 0.72% to $84.2 million in 2024, then gained by 4.97% to $88.4 million in 2025, then gained by 5.16% to $93.0 million in 2026.
• The last three Current Deferred Revenue figures came in at $93.0 million (Q2 2026), $106.4 million (Q1 2026), and $88.4 million (Q4 2025), per Business Quant data.